DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Adams DH, Kinon BJ, Baygani S et al.
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia.
BMC psychiatry 2013;
13: 143
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.